These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 7346739

  • 1. Apparent Michaelis-Menten kinetic parameters of phenytoin in pediatric patients.
    Chiba K, Ishizaki T, Miura H, Minagawa K.
    Pediatr Pharmacol (New York); 1980; 1(2):171-80. PubMed ID: 7346739
    [Abstract] [Full Text] [Related]

  • 2. Influence of bioavailability on the calculated Michaelis-Menten parameters of phenytoin in children.
    Koren G, Brand N, MacLeod SM.
    Ther Drug Monit; 1984; 6(1):11-4. PubMed ID: 6710554
    [Abstract] [Full Text] [Related]

  • 3. Dose adjustment of phenytoin for comedication in Japanese patients with epilepsy.
    Fukuoka N, Uno J, Tsukamoto T, Houchi H, Kimura M, Morita S.
    Ther Drug Monit; 2009 Feb; 31(1):57-62. PubMed ID: 19077928
    [Abstract] [Full Text] [Related]

  • 4. Phenytoin--allopurinol interaction: Michaelis--Menten kinetic parameters of phenytoin with and without allopurinol in a child with Lesch--Nyhan syndrome.
    Yokochi K, Yokochi A, Chiba K, Ishizaki T.
    Ther Drug Monit; 1982 Feb; 4(4):353-7. PubMed ID: 7157458
    [Abstract] [Full Text] [Related]

  • 5. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E, Cloyd J, Critchley D, Fuseau E.
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [Abstract] [Full Text] [Related]

  • 6. Phenytoin dosage requirements and pharmacokinetic variables.
    Taylor JW, Murphy MJ, Berg MJ, Perry PJ, Lyon LW, Ludden TM.
    Clin Pharm; 1983 Jul; 2(3):253-7. PubMed ID: 6883953
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic drug monitoring and clinical outcomes in epileptic Egyptian patients: a gene polymorphism perspective study.
    Ebid AH, Ahmed MM, Mohammed SA.
    Ther Drug Monit; 2007 Jun; 29(3):305-12. PubMed ID: 17529887
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic drug monitoring of antiepileptic drugs.
    Shakya G, Malla S, Shakya KN, Shrestha R.
    JNMA J Nepal Med Assoc; 2008 Jun; 47(171):94-7. PubMed ID: 19079370
    [Abstract] [Full Text] [Related]

  • 9. Phenytoin Michaelis-Menten pharmacokinetics in Saudi patients.
    el-Sayed YM, Islam SI.
    Int J Clin Pharmacol Ther Toxicol; 1989 Apr; 27(4):173-8. PubMed ID: 2714918
    [Abstract] [Full Text] [Related]

  • 10. [Population kinetic program for Michaelis-Menten elimination].
    Lü M, Zhou HW, Song JF.
    Zhongguo Yao Li Xue Bao; 1990 Jan; 11(1):85-8. PubMed ID: 2403022
    [Abstract] [Full Text] [Related]

  • 11. Modelling of the pharmacodynamic interaction between phenytoin and sodium valproate.
    Della Paschoa OE, Voskuyl RA, Danhof M.
    Br J Pharmacol; 1998 Dec; 125(7):1610-6. PubMed ID: 9884091
    [Abstract] [Full Text] [Related]

  • 12. Lack of a clinically significant effect of zonisamide on phenytoin steady-state pharmacokinetics in patients with epilepsy.
    Levy RH, Ragueneau-Majlessi I, Garnett WR, Schmerler M, Rosenfeld W, Shah J, Pan WJ.
    J Clin Pharmacol; 2004 Nov; 44(11):1230-4. PubMed ID: 15496640
    [Abstract] [Full Text] [Related]

  • 13. Phenytoin: effective but insidious therapy for epilepsy in people with intellectual disability.
    Iivanainen M.
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():24-31. PubMed ID: 10030428
    [Abstract] [Full Text] [Related]

  • 14. Kinetics of intravenous phenytoin in children.
    Koren G, Brand N, Halkin H, Dany S, Shahar E, Barzilay Z.
    Pediatr Pharmacol (New York); 1984 Dec; 4(1):31-8. PubMed ID: 6739185
    [Abstract] [Full Text] [Related]

  • 15. [Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study].
    Hernández R, Fernández Mde L, Miranda G, Suástegui R.
    Rev Invest Clin; 2005 Dec; 57(4):522-31. PubMed ID: 16315636
    [Abstract] [Full Text] [Related]

  • 16. The clearance of anticonvulsant drugs in pregnancy.
    Lander CM, Livingstone I, Tyrer JH, Eadie MJ.
    Clin Exp Neurol; 1981 Dec; 17():71-8. PubMed ID: 7346203
    [Abstract] [Full Text] [Related]

  • 17. Effect of piperine on the steady-state pharmacokinetics of phenytoin in patients with epilepsy.
    Pattanaik S, Hota D, Prabhakar S, Kharbanda P, Pandhi P.
    Phytother Res; 2006 Aug; 20(8):683-6. PubMed ID: 16767797
    [Abstract] [Full Text] [Related]

  • 18. [Blood levels of phenytoin. Pharmacokinetics and individualization of dosages in controlled children with crises and with persistence of crises].
    García-Márquez F, Rodríguez-Blancas MC, Juárez-Olguín H, Díaz-López B, Ruiz-Chávez J.
    Bol Med Hosp Infant Mex; 1990 Oct; 47(10):682-8. PubMed ID: 2278644
    [Abstract] [Full Text] [Related]

  • 19. Phenytoin Michaelis-Menten pharmacokinetics in Caucasian paediatric patients.
    Bauer LA, Blouin RA.
    Clin Pharmacokinet; 1983 Oct; 8(6):545-9. PubMed ID: 6653035
    [Abstract] [Full Text] [Related]

  • 20. [NONMEM approach for estimating population pharmacokinetic parameters of phenytoin in Chinese epileptics].
    Rui JZ, Cai MH, Chu XM, Chen G.
    Yao Xue Xue Bao; 1995 Oct; 30(3):172-8. PubMed ID: 7639079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.